Form 4: InMed Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
ADAR1 Capital Management, LLC and 1 other reported changes in beneficial ownership of InMed Pharmaceuticals Inc. common stock on October 1, 2026.
Summary
- Open-market purchase: acquired 16,431 Common Shares at $1.33 ($21,850) on October 1, 2026; holds 908,532 after (Indirect).
- Open-market purchase: acquired 8,307 Common Shares at $1.33 ($11,048) on October 2, 2026; holds 916,839 after (Indirect).
- Open-market purchase: acquired 18,182 Common Shares at $1.33 ($24,182) on October 5, 2026; holds 935,021 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $57,080, committing personal capital to the stock.
Insider Transactions
ADAR1 Capital Management, LLC — 10% owner
Daniel Schneeberger — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market purchase | Common Shares | 16,431 | $1 | $21.8K | 908,532 |
| 2026-10-02 | Open-market purchase | Common Shares | 8,307 | $1 | $11.0K | 916,839 |
| 2026-10-05 | Open-market purchase | Common Shares | 18,182 | $1 | $24.2K | 935,021 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market purchase (16,431 shares) |
| 2026-10-02 | Open-market purchase (8,307 shares) |
| 2026-10-05 | Open-market purchase (18,182 shares) |
Keywords
insider transaction, Form 4, INM, InMed Pharmaceuticals Inc., bullish, ADAR1 Capital Management, LLC, Daniel Schneeberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.